Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 10,988 | 9,623 | 10,104 | 9,488 | 8,189 |
| Operating Income | -10,988 | -9,623 | -10,104 | -9,488 | -8,189 |
| Interest Expense | 652 | 839 | 1,192 | 980 | 1,008 |
| Other Income | 1,643 | 3,563 | 3,274 | 415 | 413 |
| Pre-tax Income | -9,997 | -6,899 | -8,022 | -10,053 | -8,784 |
| Net Income Continuous | -9,997 | -6,899 | -8,022 | -10,053 | -8,784 |
| Net Income | $-9,997 | $-6,899 | $-8,022 | $-10,053 | $-8,784 |
| EPS Basic Total Ops | -0.90 | -0.83 | -1.75 | -2.27 | -2.05 |
| EPS Basic Continuous Ops | -0.90 | -0.83 | -1.74 | -2.27 | -2.05 |
| EPS Diluted Total Ops | -0.90 | -0.83 | -1.75 | -2.27 | -2.05 |
| EPS Diluted Continuous Ops | -0.90 | -0.83 | -1.74 | -2.27 | -2.05 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.83 | -1.81 | N/A | N/A |
| EBITDA(a) | $-11,664 | $-10,192 | $-9,846 | $-9,278 | $-7,879 |